Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Surgical Treatment Strategies for Moderate Ischemic Mitral Regurgitation

NCT06408779 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.

NCT NCT06408779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06408779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Surgical Treatment Strategies for Moderate Ischemic Mitral Regurgitation
Lead sponsor
China National Center for Cardiovascular Diseases
Phase
Observational
Overall status
Completed
Start date
August 1, 2023
Completion date
April 1, 2024
Enrollment
464 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery bypass, mitral valve annuloplasty, mitral valve insufficiency